QuantumScape Reports Q2 Net Loss of $114.7M, Adjusted EBITDA Loss Aligns with Expectations; Full-Year Guidance for Adjusted EBITDA Loss Narrowed to $250M-$270M

Reuters
2025/07/24
QuantumScape Reports <a href="https://laohu8.com/S/QTWO">Q2</a> Net Loss of $114.7M, Adjusted EBITDA Loss Aligns with Expectations; Full-Year Guidance for Adjusted EBITDA Loss Narrowed to $250M-$270M

QuantumScape Corporation has reported its financial results for the second quarter of 2025. The company recorded a GAAP net loss of $114.7 million and an adjusted EBITDA loss of $63.0 million, which was in line with expectations. Capital expenditures for the quarter were $8.3 million, primarily supporting facilities and equipment purchases for higher-volume QSE-5 B1 sample production using the Cobra separator process. QuantumScape has narrowed its full-year guidance for capital expenditures to a range of $45 million to $65 million and its full-year guidance for adjusted EBITDA loss to a range of $250 million to $270 million. The company ended the quarter with $797.5 million in liquidity, extending its cash runway guidance into 2029, a six-month improvement over previous guidance. A significant operational update includes the expansion of QuantumScape's collaboration and licensing arrangement with Volkswagen Group's battery maker, PowerCo. This upgraded deal involves additional payments of up to $131 million over the next two years to support joint commercialization activities, with the first milestones linked to expected payments of more than $10 million already achieved.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. QuantumScape Corporation published the original content used to generate this news brief on July 23, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10